BWA-522 intermediate-3 is an intermediate in the synthesis of BWA-522, a small-molecule, orally active proteolysis-targeting chimera (PROTAC) that potently degrades both full-length androgen receptor (AR-FL) and androgen receptor splice variant 7 (AR-V7).